NCT05638776: Treatment of Chronic Obstructive Pulmonary Disease (COPD) with Diffusion Capacity Defect by REGEND001 Cell Therapy |
|
|
| Active, not recruiting | 2 | 58 | RoW | REGEND001 cell therapy, Placebo | Regend Therapeutics, The First Affiliated Hospital of Guangzhou Medical University, Southwest Hospital, China, Shanghai Zhongshan Hospital, China-Japan Friendship Hospital, Shanghai East Hospital, Regend Therapeutics XLotus (Jiangxi) Co, Ltd., The First Affiliated Hospital of Nanchang University, Xiangya Hospital of Central South University, The First Affiliated Hospital of Soochow University | Chronic Obstructive Pulmonary Disease | 06/25 | 12/25 | | |
